Pharma and Biotech Daily: Lupus Breakthroughs, Drug Discovery Solutions, and Industry Updates

Pharma and BioTech Daily

Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world.Biogen and UCB recently achieved unexpected success with their late-stage trial for dapirolizumab pegol in lupus. This has led to plans for a second trial by the end of the year. At the American College of Rheumatology meeting, investigational CAR T therapies for lupus were highlighted, showing potential effectiveness. SignalChem Biotech is offering kinase drug discovery solutions, providing a promising avenue for future developments in the field. Additionally, there are reports of potential competition between BridgeBio and Pfizer, as well as Neurogene dropping a gene therapy program. Updates on Merck's Keytruda and Lilly's cholesterol pill are also making waves in the industry.These advancements in biotech and pharma highlight the ongoing progress and innovation in the field. Stay tuned for more updates on job opportunities in the biotech industry and other important news.